Tigrox Imuglo

The active ingredients in IMUGLO are Maritech Organic Mekabu Fucoidan Seaweed Extract from Australia, Eldercraft European Black Elderberry from Italy, PUREWAY-C Ascorbic Acid from the United States and Maitake Mushroom Mycelium Extract.

Maritech organic mekabu fucoidan seaweed extract is extracted from mekabu brown seaweed known as Undaria Pinnatifida, using a solvent-free aqeuos extraction technology. It contains fucoidan, which is powerful bioactive compound in modulating the immune system. Fucoidan also exhibits anti-viral, anti-bacterial, anti-aging and anti-inflammatory properties.

ElderCraft Black Elderberry extract is a high-quality elderberry extract with standardized 14% of anthocyanidins manufactured from Austrian black elderberries (Sambucus Nigra L.). It is extracted using patented Iprona Polyphenol membrane filtration technology to retain the maximum content of phytonutrients in the black elderberry. The main functions of ElderCraft are to help support immunity, reduce risk of infection and relieve upper respiratory symptoms.

PUREWAY-C is a form of high bioavailability vitamin C. With SuperSorb Enhanced Delivery Systems, PUREWAY-C is having better delivery, absorption rate and utilization efficacy, and its retention rate is 233% compared to other form of vitamin C. It is effective in maintaining healthy immune function and supporting immunomodulatory functions in human body.

Maitake mushroom is rich in beta-1,3-1,6 glucan which are potent immunomodulators that help to restore healthy immune balance. Moreover, it also contributes to anti-allergic properties that can improve body resistance against allergies.

Maritech organic mekabu fucoidan seaweed extract contains more than 85% of fucoidan.

ElderCraft European Black Elderberry extract is extracted by the ratio of 1:64.Hence, 300mg of black elderberry extract in IMUGLO is equivalent to 19200mg of elderberry fruit .

IMUGLO is a functional food instead of a supplement. According to the food classification letter by NPRA, IMUGLO is not regulated by DCA (Drug Control Authority), NPRA, it is under regulation by BKKM of the Ministry of Health.

IMUGLO is suitable for people who are having weak immune systems and people who are risk of low immunity, such as people who are taking certain medications or having certain diseases, poor nutrition, under long term stress, smoking and alcohol abuse.

People who have had an organ transplant and are taking immunosuppressant drugs should avoid taking IMUGLO. Besides, people who are taking warfarin blood thinner should avoid taking IMUGLO too. For those who are allergic to seaweed, elderberry and mushroom, they are also not suitable to take IMUGLO.